AR and posterior cortical atrophy: Recently, Ledt et al. analyzed the circulating tumour cell free DNA (cfDNA) of 892 patients with advanced PCa, and demonstrated that 32% of patients with AR alterations present nonsynonymous mutations (SNVs or indels) [17].